Norharmane as a potential chemical entity for development of anticancer drugs

This publication has 39 references indexed in Scilit:

• 7,8-Dichloro-1-oxo-β-carbolines as a Versatile Scaffold for the Development of Potent and Selective Kinase Inhibitors with Unusual Binding Modes
  Journal of Medicinal Chemistry, 2012
• Alkaloids Isolated from Natural Herbs as the Anticancer Agents
  Evidence-Based Complementary and Alternative Medicine, 2012
• Pharmacodynamics of dietary phytochemical indoles I3C and DIM: Induction of Nrf2-mediated phase II drug metabolizing and antioxidant genes and synergism with isothiocyanates
  Biopharmaceutics & Drug Disposition, 2011
• Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals
  Cancer and Metastasis Reviews, 2010
• Cellular Uptake, Cytotoxicity, and Metabolic Profiling of Human Cancer Cells Treated with Ruthenium(II) Polypyridyl Complexes [Ru(bpy)₂(N-N)]Cl₂ with N-N=bpy, phen, dpq, dppz, and dppn
  ChemMedChem, 2008
• Methods to Explore Cellular Uptake of Ruthenium Complexes
  Journal of the American Chemical Society, 2006
• Human monoamine oxidase enzyme inhibition by coffee and β-carbolines norharman and harman isolated from coffee
  Life Sciences, 2006
• Synthesis, acute toxicities, and antitumor effects of novel 9-substituted β-carboline derivatives
  Bioorganic & Medicinal Chemistry, 2004
• Beta-Carboline Alkaloids in Crude Drugs.
  Chemical and Pharmaceutical Bulletin, 1999
• The simple β-carboline alkaloids
  Phytochemistry, 1980